CIBC Bancorp USA’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.55M Sell
17,666
-3,559
-17% -$1.26M 0.01% 664
2026
Q2
$7.62M Sell
21,225
-6,199
-23% -$1.9M 0.01% 616
2026
Q1
$6.87M Buy
+27,424
New +$6.82M 0.01% 618
2025
Q3
$2.6M Buy
+9,919
New +$2.41M 0.01% 546

Other funds holding WST

CIBC Bancorp USA's WST Position: Q3 2026 in Review

CIBC Bancorp USA reduced its West Pharmaceutical (WST) stake by 17% in Q3 2026, selling an estimated $1.26M and leaving 17,666 shares worth $6.55M. The position accounts for 0.01% of the portfolio, ranked #664.

CIBC Bancorp USA first reported a position in WST in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.62M in Q2 2026. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • CIBC Bancorp USA held 17,666 shares of West Pharmaceutical worth $6.55M as of Q3 2026.
  • CIBC Bancorp USA sold 3,559 West Pharmaceutical shares in Q3 2026, an estimated $1.26M.
  • West Pharmaceutical made up 0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #664 holding.
  • CIBC Bancorp USA first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's West Pharmaceutical position peaked at $7.62M in Q2 2026.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.